BIOVIE DIRECT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOVIE DIRECT
Largest movements
- Stocks and contracts -€6,347
down €6,347 (-25.7%), from €24,678 to €18,331
- Cash +€795
up €795 (+22.9%), from €3,467 to €4,263
mainly Stocks and contracts (+€6,347) and Debts after one year (+€953)
- Receivables within one year -€378
down €378 (-26.5%), from €1,431 to €1,052
of which Trade receivables: -€397
- Profit (loss) carried forward -€7,285
down €7,285 (-23.5%), from -€30,976 to -€38,261
- Debts after one year +€953
up €953 (+2.3%), from €40,724 to €41,677
- Tax, wage and social debts +€628
up €628 (+320%), from €197 to €825
- Other operating charges +€256
up €256 (+92.2%), from €278 to €533
- Gross operating margin -€99
down €99 (-1.5%), from -€6,580 to -€6,679
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €29,576 | €23,646 | -€5,930 | -20.1% |
| Current assets | 29/58 | €29,576 | €23,646 | -€5,930 | -20.1% |
| Stocks and contracts in progress | 3 | €24,678 | €18,331 | -€6,347 | -25.7% |
| Stocks | 30/36 | €24,678 | €18,331 | -€6,347 | -25.7% |
| Amounts receivable within one year | 40/41 | €1,431 | €1,052 | -€378 | -26.5% |
| Trade receivables | 40 | €1,399 | €1,002 | -€397 | -28.4% |
| Other amounts receivable | 41 | €32 | €51 | +€19 | +59.5% |
| Cash at bank and in hand | 54/58 | €3,467 | €4,263 | +€795 | +22.9% |
| Total equity and liabilities | 10/49 | €29,576 | €23,646 | -€5,930 | -20.1% |
| Equity | 10/15 | -€12,134 | -€19,419 | -€7,285 | -60.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €242 | €242 | = | 0.0% |
| Non-distributable reserves | 130/1 | €242 | €242 | = | 0.0% |
| Reserves not available under the articles | 1311 | €242 | €242 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€30,976 | -€38,261 | -€7,285 | -23.5% |
| Amounts payable | 17/49 | €41,710 | €43,065 | +€1,355 | +3.2% |
| Amounts payable after more than one year | 17 | €40,724 | €41,677 | +€953 | +2.3% |
| Other amounts payable | 178/9 | €40,724 | €41,677 | +€953 | +2.3% |
| Amounts payable within one year | 42/48 | €986 | €1,387 | +€402 | +40.7% |
| Trade debts | 44 | €789 | €562 | -€227 | -28.7% |
| Suppliers | 440/4 | €789 | €562 | -€227 | -28.7% |
| Taxes, remuneration and social security | 45 | €197 | €825 | +€628 | +320% |
| Taxes | 450/3 | €197 | €825 | +€628 | +320% |
| Other operating charges | 640/8 | €278 | €533 | +€256 | +92.2% |
| Gross operating margin | 9900 | -€6,580 | -€6,679 | -€99 | -1.5% |
| Operating profit (loss) | 9901 | -€6,858 | -€7,212 | -€355 | -5.2% |
| Financial income | 75/76B | €10 | €10 | -€0 | -4.9% |
| Recurring financial income | 75 | €10 | €10 | -€0 | -4.9% |
| Financial charges | 65/66B | €80 | €82 | +€3 | +3.4% |
| Recurring financial charges | 65 | €80 | €82 | +€3 | +3.4% |
| Profit (loss) for the period before taxes | 9903 | -€6,927 | -€7,285 | -€358 | -5.2% |
| Profit (loss) for the period | 9904 | -€6,927 | -€7,285 | -€358 | -5.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€6,927 | -€7,285 | -€358 | -5.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.